<DOC>
	<DOCNO>NCT02936505</DOCNO>
	<brief_summary>A controlled randomized , open-label , multi-centre study evaluate immunosuppressive protocol , base ATG-induction , daily tacrolimus-dose ( Advagraf® ) , mycophenolate mofetil corticosteroid reduces incidence chronic lung allograft dysfunction ( CLAD ) lung transplantation , comparison standard cyclosporin-based protocol .</brief_summary>
	<brief_title>Clinical Study Evaluating Two Treatment Protocols Immunosuppresive Drugs . Looking 3-year Incidence CLAD .</brief_title>
	<detailed_description>Study purpose : To evaluate whether use once-daily tacrolimus-dose regimen ( Advagraf® ) , base anti-thymocyte globuline ( Thymoglobulin® ) induction , mycophenolate mofetil ( MMF ) corticosteroid , reduces cumulative incidence CLAD de novo lung transplantation 36 month , comparison twice-daily cyclosporin-based protocol , otherwise identical group .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female lung recipient 1870 year age undergoing primary double ( include size reduction ) lung transplantation . 2 . Patient willing capable give write informed consent study participation anticipate able participate study 36 month . Exclusion Criteria 1 . Recipients multiorgan transplant , previously transplant organ , include previous lung transplantation . 2 . Patients hypersensitivity , reason able take immunosuppressive drug use study . 3 . Donor lung cold ischemic time &gt; 12 hour . 4 . Patients previously treat antithymocyte globuline preparation ( e.g . ATGFresenius® , Thymoglobulin® ) . 5 . Patients recipient ABOincompatible transplant . 6 . Patients platelet count &lt; 50,000/mm3 evaluation transplantation . 7 . Patients unlikely comply study requirement . 8 . Patients , and/or receive organ donor , positive HIV , Hepatitis B surface antigen Hepatitis C virus . 9 . Patients donor great 75 year . 10 . Patient receive unlicensed drug therapy within one month prior study entry therapy institute posttransplantation . 11 . Patient unable participate study full 36month period 12 . Patients past ( within past 35 year ) present malignancy ( excise basal cell carcinoma ) . 13 . Females capable become pregnant must negative pregnancy test prior randomization . Females recommend practice medically approve method birth control duration study period 8 week follow discontinuation study medication , even history infertility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>chronic lung allograft dysfunction</keyword>
	<keyword>cyclosporin</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>Bronchiolitis Obliterans Syndrome</keyword>
	<keyword>Restrictive Allograft Syndrome</keyword>
	<keyword>CLAD</keyword>
</DOC>